PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 19, 2022JAMA Neurology233 citationsOpen Access

Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease

SOSusanne OstrowitzkiTBTobias BittnerKSKaycee M. Sink

Key Points

Key points are not available for this paper at this time.

Abstract

ClinicalTrials.gov Identifiers: CREAD, NCT02670083; CREAD2, NCT03114657.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ostrowitzki et al. (2022) studied this question.

synapsesocial.com/papers/69dab5660f32475823a3d9dahttps://doi.org/10.1001/jamaneurol.2022.2909
Ask AI
Helpful
Bookmark
Share
View Full Paper